Studies to determine the molecular basis of responsiveness to the novel anti-leukaemic drug PEP005 in human AML cells

Project Details

Short titleStudies to determine the molecular basis of responsiveness to the novel anti-leukaemic drug PEP005 in human AML cells
StatusFinished
Effective start/end date3/07/062/10/06

Funding

  • THE WELLCOME TRUST